HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

World Health Organization Classification and Diagnosis of Mastocytosis: Update 2023 and Future Perspectives.

Abstract
Experts of the European Competence Network on Mastocytosis (ECNM) and the American Initiative on Mast Cell Disorders have discussed and updated diagnostic criteria and the classification of mastocytosis, based on new insights in the field and data collected in recent years, mostly within ECNM registry projects in which studies on several thousand cases have been performed. Based on this proposal, the World Health Organization has updated its classification of mastocytosis. This article discusses the revised classification of mastocytosis in light of a rapidly moving field and the advent of new diagnostic parameters, new prognostication tools, and new therapies.
AuthorsPeter Valent, Karl Sotlar, Hans-Peter Horny, Michel Arock, Cem Akin
JournalImmunology and allergy clinics of North America (Immunol Allergy Clin North Am) Vol. 43 Issue 4 Pg. 627-649 (11 2023) ISSN: 1557-8607 [Electronic] United States
PMID37758403 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2023 Elsevier Inc. All rights reserved.
Topics
  • Humans
  • Mastocytosis (diagnosis, genetics, therapy)
  • World Health Organization
  • Mast Cells

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: